TrialScientific reports2022

Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial.

Alberto Cecconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.